Award

Farese and Walther find depth in a droplet

They have won the 2022 ASBMB–Merck Award
Renae   Crossing
Dec. 15, 2021

“Tobi was a very rare type of person. … When you do a sabbatical many people in the lab ignore you, but Tobi ... without hesitation, said, ‘I’ll help you. Let’s go.’”

Robert Farese Jr.

In this way, Tobias Walther’s simple question (“What are you working on?”) to Robert Farese Jr. started a long-term collaboration that has become the forefront research group in a new field of biology: how and why our cells make little droplets, called lipid droplets, and why that matters.

In the early 1990s, Farese had been studying enzymes that make oils. In his science, as in his photography, Farese looks deeply at everyday things others pass over. Lipid droplets had been observed under microscopes since the 1800s, but Farese said, “When I went to the textbooks and tried to learn about them as organelles, I couldn’t find anything.”

Tobias Walther

Farese and Walther converged from complementary paths: one a U.S. lipid biologist with an M.D., the other a German chemist and biochemist who was a postdoc at the time. Additionally pooling structural biology, biophysics, proteomics, enzymology and physiology, over time they created excellent science.

“We stand on the shoulders of some amazing scientists,” Walther said, “but they didn’t have the tools that we have.”

For what they’ve done with these tools, Walther and Farese, now running a joint lab at Harvard University and both associate members of the Broad Institute, have won the 2022 American Society for Biochemistry and Molecular Biology’s ASBMB–Merck Award.

Droplets by nature are isolated, but good science isn’t. For Walther, “It’s about the work and not (the two of us) … many people in our lab have contributed.” Farese attributes asking good questions to their “constant creative dialogue … ping ponging” ideas for experiments. Both buck egomania in science, appreciating a congratulatory note from mentors over a press release.

Feedback on the science itself, says Walther, is what shows “we’re on the right track.” That track increasingly has shown that there’s depth in a droplet, and there’s yet more to be found.

Two make one

Two enzymes inside us, DGAT1 and DGAT2, like Tobias Walther and Robert Farese Jr., converge with their distinct pathways to work on a common process: encasing energy-rich molecules safely in lipid droplets. (And one of them is shaped like a butterfly.) Lipids left alone to accumulate can be toxic, so it’s safer to bundle them together.

Inside lipid droplets are fats, or triacylglycerides: esters of fatty acids and glycerol. Their presence makes cells an emulsion, Farese explains, and while we know in terms of physics how emulsions form, in biochemistry, questions arise about “how nature evolved proteins and lipids to govern that process in a regulated way.”

Knowing how fats are metabolized has consequences: mutated versions of DGAT1 cause congenital diarrhea syndrome, and physicians may soon block DGAT2 to treat nonalcoholic fatty liver disease; the latter is in clinical trials. Overactive versions of DGAT enzymes will have plants and microbes producing oils for food or fuel for us.

And regarding obesity and conditions where people are underweight, Walther wants people to know, “We’re making a lot of progress, and there’s a lot of hope.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Renae   Crossing

Renae Crossing is a writer and former teacher. She holds a first-class master’s degree in life science from the Hong Kong University of Science and Technology and a first-class master’s in teaching from the University of Melbourne.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Finding a symphony among complex molecules
Profile

Finding a symphony among complex molecules

April 23, 2025

MOSAIC scholar Stanna Dorn uses total synthesis to recreate rare bacterial natural products with potential therapeutic applications.

Sketching, scribbling and scicomm
Science Communication

Sketching, scribbling and scicomm

April 16, 2025

Graduate student Ari Paiz describes how her love of science and art blend to make her an effective science communicator.

Embrace your neurodivergence and flourish in college
Diversity

Embrace your neurodivergence and flourish in college

April 14, 2025

This guide offers practical advice on setting yourself up for success — learn how to leverage campus resources, work with professors and embrace your strengths.

Survival tools for a neurodivergent brain in academia
Essay

Survival tools for a neurodivergent brain in academia

April 10, 2025

Working in academia is hard, and being neurodivergent makes it harder. Here are a few tools that may help, from a Ph.D. student with ADHD.

Quieting the static: Building inclusive STEM classrooms
Interview

Quieting the static: Building inclusive STEM classrooms

April 8, 2025

Christin Monroe, an assistant professor of chemistry at Landmark College, offers practical tips to help educators make their classrooms more accessible to neurodivergent scientists.

Hidden strengths of an autistic scientist
Essay

Hidden strengths of an autistic scientist

April 3, 2025

Navigating the world of scientific research as an autistic scientist comes with unique challenges —microaggressions, communication hurdles and the constant pressure to conform to social norms, postbaccalaureate student Taylor Stolberg writes.